|
Call for Abstracts
2nd Round |
|
Just Announced! A Second Call for Abstracts is now open to accept new abstracts and late-breaking abstracts. Deadline for this submission will be Wednesday, September 11, 2019. No extensions to this deadline will be offered.
Important Deadlines:
Call for Abstracts opens |
March 2019 |
Online registration opens |
March 2019 |
Abstract submission deadline |
July 5, 2019 |
Notice of Abstract adjudication |
July 22, 2019 |
2nd Call for Abstracts submission opens (for regular and late-breaking) |
August 2019 (open now) |
Deadline for presenting authors to register |
August 30, 2019 |
Early registration deadline |
August 30, 2019 |
2nd Call for Abstract/Late-breaking submission deadline |
September 11, 2019 |
Hotel booking deadline (based on availability) |
October 1, 2019 |
Abstract Format
Please indicate your preference for oral or poster presentation in the online submission. If you are interested in an oral presentation, it is highly recommended that you submit your abstract for both oral or poster presentation, as there are only a small number of oral presentations to be filled. Those submitted for oral presentation only that are not accepted for poster presentation will be rejected.
An acknowledgement of your abstract submission(s) will be sent via email.
Abstracts will be peer reviewed, following the submission deadline on Wednesday, September 11, 2019. This submission deadline will not be extended. Notifications will be sent to the accepted abstract submitters.
Topics
Please submit your abstract by selecting one category out of the following that best describes its scientific content. Categories will be used for reviewing and indexing purposes.
Disclosure of Conflict
Authors are required to complete a Disclosure of Conflict form as part of the abstract submission. These will be included in the Final Program. Abstracts must be free of commercial bias and should only identify drug products by their generic names.
Condition of Acceptance
A condition of acceptance is that you must register for the conference. Conference registration must be received by Friday, September 20 in order for the abstract to be included in the program.
Please indicate your preference for oral or poster presentation in the online submission. If you are interested in an oral presentation, it is highly recommended that you submit your abstract for both oral or poster presentation, as there are only a small number of oral presentations to be filled. Those submitted for oral presentation only that are not accepted for poster presentation will be rejected.
An acknowledgement of your abstract submission(s) will be sent via email.
Abstracts will be peer reviewed, following the submission deadline on Wednesday, September 11, 2019. This submission deadline will not be extended. Notifications will be sent to the accepted abstract submitters.
Topics
Please submit your abstract by selecting one category out of the following that best describes its scientific content. Categories will be used for reviewing and indexing purposes.
- Epidemiology and Health Services Research
- Clinical Research including Quality of Life
- Comorbidities and complications
- Clinical trial research & innovation
- Basic & Translational research
- Medical treatments and wound care
- Surgical and interventional treatments
Disclosure of Conflict
Authors are required to complete a Disclosure of Conflict form as part of the abstract submission. These will be included in the Final Program. Abstracts must be free of commercial bias and should only identify drug products by their generic names.
Condition of Acceptance
A condition of acceptance is that you must register for the conference. Conference registration must be received by Friday, September 20 in order for the abstract to be included in the program.
Abstract Submission Process - 2nd Round
Abstracts submissions will be accepted via the online submission system only by clicking on the "Online Submission" above. Abstracts sent by email or mail will not be accepted.
All abstracts submitted must select from one of the conference topics for inclusion in the program. Abstracts should present new information, and not have been submitted or published elsewhere (at the time of submission). When submitting an abstract, please select the topic that best applies to your abstract. Topics can be selected from the drop-down menu of the online submission system.
Submitting authors and/or presenters may modify their submission(s) until the closing date of September 11, 2019 at 5:00pm PST.
Abstracts selected for poster or oral presentations in the 4th Annual Symposium on HS Advances will be reproduced exactly as submitted and substitutions will not be permitted. Be sure to proofread your abstract very carefully before submitting. Abstracts will be published as a proceeding report in the Journal of Experimental Dermatology.
Abstract Guidelines
2. Methods, Results
3. Conclusions
Travel Grants
For info on travel grants, click here.
Abstracts submissions will be accepted via the online submission system only by clicking on the "Online Submission" above. Abstracts sent by email or mail will not be accepted.
All abstracts submitted must select from one of the conference topics for inclusion in the program. Abstracts should present new information, and not have been submitted or published elsewhere (at the time of submission). When submitting an abstract, please select the topic that best applies to your abstract. Topics can be selected from the drop-down menu of the online submission system.
Submitting authors and/or presenters may modify their submission(s) until the closing date of September 11, 2019 at 5:00pm PST.
Abstracts selected for poster or oral presentations in the 4th Annual Symposium on HS Advances will be reproduced exactly as submitted and substitutions will not be permitted. Be sure to proofread your abstract very carefully before submitting. Abstracts will be published as a proceeding report in the Journal of Experimental Dermatology.
Abstract Guidelines
- Prepare your abstract in MS Word
- Do not use presentation software, such as PowerPoint
- Limit your abstract (body) to no more than 300 words
- It is suggested, other than case presentations, to separate your abstract into three (3) paragraphs:
2. Methods, Results
3. Conclusions
- Include learning objectives and a takeaway message.
Travel Grants
For info on travel grants, click here.